par Fizazi, Karim;Lipton, Allan;Mariette, Xavier;Body, Jean-Jacques ;Rahim, Yasmin;Gralow, Julie R;Gao, Guozhi M.;Wu, Ling;Sohn, Winnie;Jun, Susie
Référence Journal of clinical oncology, 27, 10, page (1564-1571)
Publication Publié, 2009-04
Référence Journal of clinical oncology, 27, 10, page (1564-1571)
Publication Publié, 2009-04
Article révisé par les pairs
Titre: |
|
Auteur: | Fizazi, Karim; Lipton, Allan; Mariette, Xavier; Body, Jean-Jacques; Rahim, Yasmin; Gralow, Julie R; Gao, Guozhi M.; Wu, Ling; Sohn, Winnie; Jun, Susie |
Informations sur la publication: | Journal of clinical oncology, 27, 10, page (1564-1571) |
Statut de publication: | Publié, 2009-04 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Aged |
Antibodies, Monoclonal -- pharmacokinetics -- therapeutic use | |
Antibodies, Monoclonal, Humanized | |
Bone Density Conservation Agents -- therapeutic use | |
Bone Neoplasms -- complications -- secondary | |
Bone Resorption -- chemically induced -- prevention & control | |
Breast Neoplasms -- pathology | |
Collagen Type I -- urine | |
Diphosphonates -- administration & dosage | |
Female | |
Humans | |
Male | |
Middle Aged | |
Multiple Myeloma -- pathology | |
Peptides -- urine | |
Prostatic Neoplasms -- pathology | |
RANK Ligand -- antagonists & inhibitors -- pharmacokinetics -- therapeutic use | |
Note générale: | Clinical Trial, Phase II |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2008.19.2146 | |
info:pii/JCO.2008.19.2146 | |
info:scp/63749094012 | |
info:pmid/19237632 |